Chao Zhou1, Yuejun Sun2, Shuwei Guo3, Xiao Chen3, Genchong Bao4, Jiandong Wang5. 1. Department of Infection, Danyang People's Hospital of Jiangsu Province, No.2 Xinmin Xi Lu, Dan Yang, Jiangsu, China. 2. Department of Pathology, Affiliated Jiangyin Hospital of Southeast University Medical College, Jiangyin, 214400, Jiangsu, China. 3. Department of Pathology, Jinling Hospital, Nanjing University School of Medicine, No.305 Zhong Shan Dong Lu, Nanjing, 210008, Jiangsu, China. 4. Department of Infection, Danyang People's Hospital of Jiangsu Province, No.2 Xinmin Xi Lu, Dan Yang, Jiangsu, China. bgc190@sina.com. 5. Department of Pathology, Jinling Hospital, Nanjing University School of Medicine, No.305 Zhong Shan Dong Lu, Nanjing, 210008, Jiangsu, China. jd_wang@outlook.com.
Abstract
BACKGROUND: Hepatocellular carcinoma (HCC) is an aggressive cancer with a poor prognosis. Effective biomarkers are necessary to predict the clinical course and outcome of patients with HCC. Wntless (Wls) is a key modulator of Wnt protein secretion and is overexpressed in various human cancers. However, the mechanism and alteration of Wls expression in HCC have not been clarified. AIMS: The aim of this study was to evaluate expression level of Wls in HCC and its clinical significance. METHODS: The levels of Wls expression were investigated in 84 HCC tissues using immunohistochemistry. RESULTS: Wls was negatively expressed in normal liver tissue and was negatively or weakly (score 0) expressed in liver cirrhosis. Twenty-eight out of 84 samples (33.3%) were negative or weakly (score 0) expressed Wls, 38 out of 84 (45.2%) moderately (1+) expressed Wls, and 18 out of 84 (21.4%) strongly (2+) expressed Wls. Wls expression was positively associated with tumor size (P = 0.005, r = 0.302), tumor TNM stage (P = 0.017, r = 0.261), AFP (P = 0.051), and HBV infection (P = 0.009, r = 0.283), and was negatively associated with differentiation (P < 0.001, r = - 0.552). No significant relationship between Wls expression and liver cirrhosis, ALT, GGT, age, sex, or tumor focality was found. CONCLUSIONS: Our data showed that Wls was differentially expressed in HCC. Statistical analysis results suggest that Wls expression might increase as HCC progresses.
BACKGROUND:Hepatocellular carcinoma (HCC) is an aggressive cancer with a poor prognosis. Effective biomarkers are necessary to predict the clinical course and outcome of patients with HCC. Wntless (Wls) is a key modulator of Wnt protein secretion and is overexpressed in various humancancers. However, the mechanism and alteration of Wls expression in HCC have not been clarified. AIMS: The aim of this study was to evaluate expression level of Wls in HCC and its clinical significance. METHODS: The levels of Wls expression were investigated in 84 HCC tissues using immunohistochemistry. RESULTS: Wls was negatively expressed in normal liver tissue and was negatively or weakly (score 0) expressed in liver cirrhosis. Twenty-eight out of 84 samples (33.3%) were negative or weakly (score 0) expressed Wls, 38 out of 84 (45.2%) moderately (1+) expressed Wls, and 18 out of 84 (21.4%) strongly (2+) expressed Wls. Wls expression was positively associated with tumor size (P = 0.005, r = 0.302), tumorTNM stage (P = 0.017, r = 0.261), AFP (P = 0.051), and HBV infection (P = 0.009, r = 0.283), and was negatively associated with differentiation (P < 0.001, r = - 0.552). No significant relationship between Wls expression and liver cirrhosis, ALT, GGT, age, sex, or tumor focality was found. CONCLUSIONS: Our data showed that Wls was differentially expressed in HCC. Statistical analysis results suggest that Wls expression might increase as HCC progresses.